Dr. Imre Lengyel is one of the people I will remember to be thankful for next Thursday. He is a senior scientist and one of the principal investigators in the Department of Ocular Biology and Therapeutics at University College, London (ranked among the top ten universities in the world). He Skyped me last year to introduce himself after reading a Friday Pearl I wrote about one of his studies.
Biosyntrx, in concert with ophthalmologists, optometrists, PhD biochemists, molecular biologists, and nutrition educators, develops evidence-based nutraceutical formulations that support optimal health - specifically the exquisitely engineered functions of the eyes, which reveal some of the earliest signs of degeneration affecting the entire body. Biosyntrx formulations are designed to address the micronutrient needs of the dry eye, cataract, macula degeneration, glaucoma and diabetic retinopathy patient. Nutrients, which have been proven to be good for the eyes, have also been proven good for the entire body.
Clinical Study Review: A Biosyntrx Editorial
The biochemistry and molecular biology genome science associated with retinal health, and particularly macular degeneration, suggests a strong connection between dietary intake, gene regulation, and disease prevention and progression.
In medical literature you expect to read debates about complications with drugs for various conditions, but now we see the public speaking out in non-medical publications.
